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Abstract: Information regarding the alteration of trabecular bone microarchitecture, which 
is one of the important criteria to estimate bone condition, induced by osteoarthritis (OA) is 
sparse. The current study therefore aimed to identify and quantify patterns of alterations in 
trabecular bone microarchitectural characteristics at tibial epiphysis induced by OA using 
in vivo microcomputed tomography. Fourteen 8-week-old female Sprague Dawley rats were 
randomly divided into control (n = 7) and OA (n = 7) groups. Rats in the OA group were 
administered monoiodoacetate into the knee-joint cavity. The tibial joints were scanned by 
in vivo microcomputed tomography at 0, 4, and 8 weeks after administration. Two-way 
analysis of variance with Tukey’s honestly significant difference post hoc test was carried 
out for statistical analyses. The results showed that patterns of alterations in the trabecular 
bone microarchitectural characteristics in the OA group were not different from those in the 
control group from 0 to 4 weeks (P . 0.05), but differed from 4 to 8 weeks (P , 0.05). In 
particular, both trabecular bone thickness and trabecular bone separation distributions over 
time (4–8 weeks) differed significantly (P , 0.05). These findings suggest that the patterns of 
bone microarchitecture changes brought about by OA should be periodically considered in the 
diagnosis and management of arthritic symptoms over time. Improved understanding of the 
alteration pattern on trabecular bone microarchitecture may assist in developing more targeted 
treatment interventions for OA.
Keywords: osteoarthritis, in vivo microcomputed tomography, trabecular bone microarchitectural 
characteristics, trabecular bone thickness distribution, trabecular bone separation distribution
Introduction
Osteoarthritis (OA) is the most common form of arthritis.1 OA is most prevalent 
in the elderly, and about 50% of adults aged 65–75 years and almost 70% of those 
75+ years suffer from this disease.2 Also, US$15 billion is estimated to be spent in 
treating arthritis annually,3 and the number affected is expected to increase from 15% 
in 1995 to 18% of the total US population in 2020.4 Therefore, the medical bill for OA 
treatment represents an increasing burden on both individuals and society, and both 
interest in and the need for degenerative arthritis research are growing.
The direct cause of OA remains unknown, although age, sex, and genetic factors 
influence the prevalence; also, a lack of complete understanding exists of long-term 
secondary effects on bones.5,6 The known secondary symptoms of knee OA are 
 currently thought to be caused by the erosion of cartilage in knee joints.7 The cartilage 
is softened and broken by erosion, resulting in the formation of osteophytes and the 
fibrosis of synovial membranes.1 Hypertrophy of joint capsules also occurs, and causes 
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pain and gradually debilitates joint function. If these changes 
worsen, a tibia plateau fracture may occur.8 Drug therapy with 
nonsteroidal anti-inflammatory drugs or surgical interventions 
such as knee replacement, arthroplasty, or osteotomy 
are commonly used for the management of degenerative 
arthritis.9–11 During pharmacological therapy or surgical 
intervention, whether to initiate the therapy or procedures, 
the type of procedure used, and the aim of management 
all depend upon the clinical judgment of the level of bone 
damage.10 However, these managements are difficult without a 
thorough understanding and comprehensive evaluation of the 
trabecular bone microarchitecture that is one of the important 
criteria to estimate bone condition.9,12 Thus, for effective 
management of the bone condition, one must understand 
the changes in trabecular bone microarchitecture caused 
by OA. Many investigators have attempted to characterize 
the changes in trabecular bone microarchitecture caused 
by OA.13–17 However, these studies, which dealt with changes 
in trabecular bone microarchitecture, had limitations in terms 
of continuous and individual tracing.13–17 In other words, they 
were insufficient because the initial changes in trabecular 
bone microarchitecture and those that occurred during disease 
progression were not taken into account, and the time course 
of changes in each animal was not traced.
We aimed to perform a quantitative analysis of the 
 patterns of changes in the bone microarchitecture at the 
tibial epiphysis of knee joints periodically and continuously 
as OA progressed. Furthermore, we intend to establish the 
standard characteristics of the knee joint trabecular bone 
microarchitecture upon development of OA, and to provide 
a greater understanding of OA from the clinical viewpoint 
and to aid in its treatment.
Materials and methods
Animal model preparation
The animal experiments in this study complied with the 
animal protection and usage guidelines and regulations of 
Yonsei University. Fourteen 6-week-old white male rats 
(Sprague Dawley rats, ∼250 ± 7 g) were used. They were 
housed at Yonsei University Laboratory Animal Research 
Center for 2 weeks to allow them to adapt to the environment 
(temperature 23°C ± 3°C, humidity 50% ± 10%). The day/
night cycle was set up every 12 hours. Animals were fed 
standard rat food (Purina, Nestlé Purina PetCare, Seoul, 
South Korea) with water available and allowed to exercise 
freely in cages. In order to minimize any potential stress 
factors, the animals were monitored throughout the duration 
of the experiment (8 weeks) by members of Yonsei University 
Laboratory Animal Research Center. It should be noted that 
the animals retained full mobility and continued to grow 
normally. Rats were classified into two groups: the induced 
osteoarthritis group (OA group; n = 7; OA1–OA7) and the 
control group, which received no intervention (CON group; 
n = 7; C1–C7). To induce OA, 1 mg monoiodoacetate (MIA) 
(Sigma-Aldrich, St Louis, MO) was dissolved in 0.05 mL 
sterile saline and injected into the right knee joint using a 
27-gauge, 0.5-inch needle.7
In vivo micro-computed tomography
Knee-joint images of the CON and OA groups were 
obtained using an in vivo micro-computed tomography 
(µ-CT) examination system (model 1076; SkyScan, 
 Kontich, Belgium) to analyze the patterns of trabecular bone 
microarchitectural changes (Figure 1). Each knee joint was 
scanned at a 35 × 35 × 35-µm isotrophic voxel resolution 
at the  beginning of the experiment (before MIA injection), 
and at 4 and 8 weeks after MIA injection to assess changes 
in trabecular bone microarchitecture. Scanning parameters 
were 100 kV tube voltage, 100 µA tube current, 1.0 mm 
filter, and a 0.7° gantry rotation angle. Flat-field correction 
and beam-hardening-factor correction were carried out to 
rectify the beam-hardening effect.11 In addition, the rats 
were anesthetized with ketamine hydrochloride (1 mL/
kg; Huons, Seoul, South Korea) and xylazine hydrochlo-
ride (0.33 mL/kg; Bayer, Seoul, South Korea) to restrict 
their movements to obtain the desired image for µ-CT 
examination. Physical monitoring systems were also used 
to observe stress levels during the scan, and a shutter was 
used to block rats’  exposure to radiation.22
Trabecular bone microarchitecture  
and volumetric bone mineral density
Following completion of the reconstruction of two-
 dimensional images from µ-CT, the trabecular bone of 
600 µm epiphysis above the growth plate was chosen as 
the volume of interest (Figure 1). Bone microarchitecture 
variables in both the CON and OA groups were bone 
volume/tissue volume (BV/TV), bone surface/bone volume 
(BS/BV), trabecular bone pattern factor (Tb.Pf), trabecular 
bone number (Tb.N), trabecular bone thickness (Tb.Th), 
and trabecular bone separation (Tb.Sp). BV/TV indicates 
the proportion of bone volume in the total tissue volume 
and is an indicator of changes in the total bone volume. 
BS/BV is the ratio of the selected bone surface to the 
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bone volume and indicates the level of bone turnover. 
Tb.Pf is an indicator of the connection level of trabecular 
bone, meaning that the higher this value is, the lower 
the connectivity and vice versa. Tb.N is the amount of 
trabecular bone per unit length, and Tb.Th is an index of 
trabecular bone thickness: the higher the value of Tb.N 
or Tb.Th, the higher the level of bone formation. Tb.Sp 
indicates the average distance between trabecular bones, 
thus the narrower the gap, the higher the bone density. 
Analyses of distributions of trabecular bone thickness and 
separation (Tb.Th and Tb.Sp distribution) were performed 
to identify the progressive heterogeneity of the trabecular 
bone microarchitecture in OA over time.26 In addition, 
volumetric bone mineral density (vBMD) was examined 
to investigate the rate of bone loss.
Validation of OA
To assess the onset and progress of OA using radiologi-
cal methods, the surface deformity and damage above the 
epiphysis were traced and observed on the reconstructed 
three-dimensional images of knee joints. Mimics 13.0 
(Materialise, Leuven, Belgium) was used to analyze exter-
nal changes in knee joints. Histological examinations were 
additionally performed to clinically validate the induction 
of OA. Rats were killed with CO
2
 immediately after µ-CT 
was performed at 8 weeks. The tissue was fixed in 10% 
paraformaldehyde for 8 hours at room temperature, and 
the remaining fixative was removed by hand-washing after 
decalcification with 15% EDTA solution. After dehydration, 
paraffin blocks were produced by impregnation and embed-
ding. Hematoxylin and eosin (H&E) staining was performed 
on knee-joint sections (4 µm thickness).
Statistical analysis
Two-way analysis of variance along with Tukey’s post hoc 
analysis were carried out to determine the significance of 
periodic changes and differences between groups (0, 4, and 
8 weeks). The criterion of significance was a value of 
Microarchitecture analysis





Figure 1 Micro-computed tomography (μ-CT) scan, 3-D reconstruction, region of interest (ROI) and volume of interest (VOI) selection, and bone microarchitecture analysis 
in 3-D trabecular bone. 
Abbreviations: BV/TV, bone volume/tissue volume; BS/BV, bone surface/bone volume; Tb.Pf, trabecular bone pattern factor; Tb.N, trabecular bone number; Tb.Th, trabecular 
bone thickness; Tb.Sp, trabecular bone separation.
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P , 0.05, and the analysis was performed using SPSS 
 version 17.0 (IBM, Armonk, NY).
Results
Alterations of microarchitectural 
characteristics (BV/TV, BS/BV, Tb.Pf,  
Tb.N, Tb.Th, Tb.Sp)
Figure 2 shows the periodic changes in microarchitectural 
characteristics for CON and OA groups and a comparison of 
the two groups for each week. In terms of periodic changes, 
comparing 4 weeks with 0 weeks, the BV/TVs of both groups 
significantly increased (CON group: 14.13% ± 4.40%; 
OA group: 15.08% ± 7.46%; P , 0.05). The BS/BVs 
of both groups decreased signif icantly (CON group: 
3.39 ± 1.40 mm-1; OA group: 3.91 ± 2.19 mm-1; P , 0.05). 
The Tb.Pfs of both groups decreased significantly (CON 
group: 2.48 ± 1.21 mm-1; OA group: 2.33 ± 2.50 mm-1; 
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Figure 2 (A–F) Relative variables of trabecular bone microarchitecture in the tibial epiphysis at weeks 0, 4, and 8 (black bar, control group; white bar, osteoarthritis group). 
Notes: *Difference between groups; **difference between weeks, P , 0.05). 
Abbreviations: BV/TV, bone volume/tissue volume; BS/BV, bone surface/bone volume; Tb.Pf, trabecular bone pattern factor; Tb.N, trabecular bone number; Tb.Th, trabecular 
bone thickness; Tb.Sp, trabecular bone separation.
0.09 ± 0.05 mm; OA group: 0.08 ± 0.04 mm; P , 0.05). 
The Tb.Sp of the OA group decreased signif icantly 
(0.03 ± 0.02 mm; P , 0.05). Comparing 8 weeks 
with 4 weeks, the BV/TV of the OA group decreased 
significantly (15.82% ± 4.78%; P , 0.05), the BS/BV of 
the OA group increased significantly (3.45 ± 1.56 mm-1; 
P , 0.05). Tb.Pf of the OA group increased significantly 
(3.70 ± 1.20 mm-1; P , 0.05). The Tb.Th of the OA group 
decreased significantly (0.07 ± 0.03 mm; P , 0.05). 
The Tb.Sp of the OA group increased signif icantly 
(0.03 ± 0.01 mm; P , 0.05). No significant changes were 
shown in the CON group (P . 0.05). In terms of differences 
between the groups, no significant difference was seen 
at both 0 and 4 weeks (P . 0.05). However, at 8 weeks, 
a 18.31% ± 9.27% difference of BV/TV occurred due 
to the reduction (15.82% ± 4.78%) in the BV/TV of the 
OA (52.5% ± 6.1%) group compared to the CON group 
(70.8% ± 4.4%) (P , 0.05). 4.02 ± 2.25 mm-1 difference 
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of BS/BV occurred due to an increase (3.45 ± 1.16 mm-1) 
in the OA group (12.10 ± 1.45 mm-1) compared to the CON 
group (8.08 ± 1.16 mm-1; P , 0.05). 3.88 ± 2.58 mm-1 
difference of Tb.Pf at 8 weeks occurred due to an increase 
(3.70 ± 1.20 mm-1) in the OA group (-3.84 ± 1.99 mm-1) 
compared to the CON group (-7.72 ± 0.86 mm-1; P , 0.05). 
0.10 ± 0.06 mm difference of Tb.Th occurred at 8 
weeks due to the reduction (0.07 ± 0.03 mm) in the OA 
group (0.31 ± 0.03 mm) compared to the CON group 
(0.40 ± 0.05 mm; P , 0.05). In terms of the Tb.Sp and Tb.N, 
no significant differences were detected between the groups 
at 0, 4, or 8 weeks (P . 0.05) (Figure 2).
Table 1 summarizes the incidence of the micorarchitec-
tural alterations in each microarchitectural parameter in terms 
of the individual analysis for the CON and OA groups. In 
the individual analysis, comparing 4 weeks with 0 weeks, 
the BV/TVs of all individuals increased. The BS/BVs of all 
individuals decreased. The Tb.Pfs of all in the CON group 
decreased, while those of two individuals in the OA group 
(OA1, OA3, 28.6%) increased. The Tb.Ns of four individuals 
in the CON and OA groups (C1, C2, C4, C5, 57.1%; OA1, 
OA2, OA3, OA6, 57.1%) decreased. The Tb.Ths of all indi-
viduals increased. The Tb.Sps of all individuals decreased. 
Comparing 8 weeks with 4 weeks, the BV/TVs of all in the 
OA group decreased. The BS/BVs of all in the OA group 
increased. The Tb.Pfs of all individuals in the OA group 
increased. The Tb.Ns of five individuals in the CON and 
OA groups (C1, C3, C4, C6, C7, 71.4%; OA1, OA2, OA3, 
OA5, OA7, 71.4%) decreased. The Tb.Ths of all individuals 
in the OA group decreased. The Tb.Sp of all animals in the 
CON group showed a reverse pattern compared to that of 
the OA group.
Distribution of trabecular bone  
thickness and separation  
(Tb.Th and Tb.Sp distribution)
Figure 3 shows a comparison of the periodic changes 
in the Tb.Th distribution of each group. In terms of the 
periodic changes in Tb.Th distribution, comparing 4 weeks 
with 0 weeks, the percentage of Tb.Th that was less than 
0.24 mm thick in the CON group decreased significantly 
(20.02% ± 7.33%; P , 0.05), and the percentage that was 
0.38–0.52 and 0.59–0.73 mm thick increased significantly 
(13.82% ± 6.79%; P , 0.05). The percentage of Tb.Th that was 
less than 0.24 mm thick in the OA group decreased significantly 
(20.33% ± 10.67%; P , 0.05), like in the CON group, and the 
percentage that was 0.31–0.52 and 0.59–0.80 mm, in contrast 
to the CON group, increased (21.67% ± 7.50%; P , 0.05). 
Comparing 8 weeks with 4 weeks, no significant differences 
were detected in the percentage of Tb.Th in the CON group 
(P . 0.05), but the percentage of Tb.Th less than 0.24 mm thick 
in the OA group increased significantly (20.33% ± 6.94%; 
P , 0.05) and that of Tb.Th that was 0.31–0.52 and 
0.59–0.80 mm thick decreased significantly (11.83% ± 3.50%; 
P , 0.05). In a comparison between groups, no significant 
difference in the Tb.Th distributions was found at 0 and 4 
weeks (P . 0.05). However, the percentage of Tb.Th less 
than 0.24 mm thick was significantly higher (21.58 ± 11.20%; 
P , 0.05) in the OA group (39.73% ± 6.71%) than in the CON 
group (18.15% ± 6.40%), and the percentage of Tb.Th thicker 
than 0.45 mm, excluding those that were 0.66–0.73 mm thick 
in the OA group (14.16% ± 7.23%), was significantly lower 
(20.54% ± 14.81%; P , 0.05) than that of the CON group 
(34.70% ± 11.06%) at 8 weeks (Figure 3).
Figure 4 shows a comparison of the periodic changes 
in the Tb.Sp distribution of each group. When compar-
ing 4 and 0 weeks, the percentage of Tb.Sp that was less 
than 0.17 mm in the CON group increased significantly 
(5.75% ± 3.07%; P , 0.05), and the percentage of Tb.Sp that 
was 0.38–0.45 mm decreased significantly (2.61% ± 2.48%; 
P , 0.05). The percentage of Tb.Sp less than 0.17 mm in 
the OA group, as in the CON group, increased significantly 
(12.69% ± 6.93%; P , 0.05) and the percentage of Tb.Sp that 
was 0.31–0.52 mm decreased significantly (10.72% ± 4.38%; 
P , 0.05). Comparing 8 weeks with 4 weeks, no significant 
Table 1 Incidence of microarchitectural alterations in each 
microarchitectural parameter in terms of the individual analysis 
for control and osteoarthritis groups










BV/TV 7 0 2 5
BS/BV 0 7 7 0
Tb.Pf 0 7 5 2
Tb.N 3 4 7 0
Tb.Th 7 0 0 7
Tb.Sp 0 7 7 0
4–8 weeks
BV/TV 3 4 0 7
BS/BV 4 3 7 0
Tb.Pf 3 4 7 0
Tb.N 2 5 0 7
Tb.Th 3 4 0 7
Tb.Sp 0 7 7 0
Abbreviations: BV/TV, bone volume/total volume; BS/BV, bone surface/
bone volume; Tb.Pf, trabecular bone pattern factor; Tb.N, trabecular number; 
Tb.Th, trabecular thickness; Tb.Sp, trabecular separation.
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Figure 3 Alteration of trabecular bone thickness distribution in the tibial epiphysis at weeks 0, 4, and 8 (vertical axis, trabecular bone thickness, mm; horizontal axis, bone 
percentage; black bar, control group; white bar, osteoarthritis group).
Notes: *Differences between groups; **difference from 0 to 4 weeks; ***difference from 4 to 8 weeks. 
Abbreviations: BV/TV, bone volume/tissue volume; BS/BV, bone surface/bone volume; Tb.Pf, trabecular bone pattern factor; Tb.N, trabecular bone number; Tb.Th, trabecular 
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Figure 4 (A–C) Alteration in trabecular bone separation distribution in the tibial epiphysis at weeks 0, 4, and 8 (vertical axis, trabecular bone separation, mm; horizontal 
axis, bone percentage; black bar, control group; white bar, osteoarthritis group). 
Notes: *Differences between groups; **0–4, difference from 0 to 4 weeks; ***4–8, difference from 4 to 8 weeks.
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difference was observed in the Tb.Sp distribution in the 
CON group (P . 0.05), but the percentage of Tb.Sp that was 
less than 0.24 mm in the OA group decreased significantly 
(12.15% ± 4.32%; P , 0.05) and the percentage of Tb.Sp 
that was 0.24–0.31, 0.45–0.52, and 0.59–0.66 mm in the OA 
group increased significantly (7.14% ± 2.22%; P , 0.05). In 
a comparison between groups, no significant difference was 
seen at 0 and 4 weeks (P . 0.05). However, the percent-
age of Tb.Sp that was less than 0.17 mm in the OA group 
(17.92% ± 2.88%) was significantly lower (8.16% ± 5.20%; 
P , 0.05) than in the CON group (25.46% ± 3.69%), and the 
percentage of Tb.Sp that was 0.24–0.31 mm in the OA group 
(27.86% ± 1.18%) was significantly higher (5.49% ± 1.65%; 
P , 0.05) than in the CON group (22.38% ± 2.16%) 
(Figure 4).
Bone mineral density
The mean changes in vBMD of the CON and OA groups 
during the 8-week follow-up are shown in Table 2. In terms 
of periodic changes, comparing 4 weeks with 0 weeks, 
the vBMD of both groups significantly increased (CON 
group 0.12 ± 0.06 g/cm3, OA group 0.11 ± 0.06 g/cm3; 
P , 0.05). Comparing 8 weeks with 4 weeks, the vBMD 
of the OA group decreased significantly (0.14 ± 0.04 g/cm3; 
P , 0.05), while no significant changes were shown in the 
CON group (P . 0.05). In terms of differences between the 
groups, at 8 weeks, 0.16 ± 0.08 g/cm3 difference in vBMD 
occurred due to the reduction (0.14 ± 0.04 g/cm3) in the 
vBMD of the OA (0.31 ± 0.05 g/cm3) group compared to 
the CON group (0.47 ± 0.05 g/cm3, P , 0.05).
Validation of OA induction
Figures 5 and 6 show the external changes in the tibial 
epiphysis of the knee joints and the level of damage in 
the OA groups in the reconstructed three-dimensional 
and histological images. No external changes, such as 
deformities or irregularity, occurred on the reconstructed 
three-dimensional µ-CT images of the OA group at 0 or 4 
weeks. In contrast, local bone erosion and osteophytes in both 
the medial and  lateral part of the tibia were evident in the OA 
group at 8 weeks, accompanied by irregular bone caused by 
osteophytes at the tibial and femoral joints (Figure 5). In the 
histological image (Figure 6), as shown in the radiographic 
image of the CON group, the histological image of the knee 
joint in the CON group showed no deformity or irregularity 
in external appearance. In contrast, in the representative H&E 
staining section of the OA group, symptoms of OA, such as 
cartilage damage, local bone erosion, synovitis, and pannus 
formation, were evident. Focal erosive area (posteroproximal 
end of the tibial epiphysis) is well correlated with the 
three-dimensional radiographic image of the OA group at 
8 weeks.  Magnification of degraded bone area showed a 
significant aggregate cell marker staining with few osteoclasts 
(multinucleate lining cells) in the subchondral bone regions 
adjacent to the osteochondral interface. In particular, synovial 
cell nuclei together with some inflammatory cells are broadly 
shown in the section.
Table 2 Changes in bone mineral density (vBMD) of control and 
osteoarthritis groups at 0, 4, and 8 weeks
Volumetric bone mineral density (g/cm3)
Control (n = 7) Osteoarthritis (n = 7)
0 weeks 0.35 ± 0.04 0.35 ± 0.04
4 weeks 0.48 ± 0.04a 0.45 ± 0.03a
8 weeks 0.47 ± 0.05 0.31 ± 0.05b,*
Notes: Values are mean ± standard deviation; asignificant changes from 0 weeks; 
bsignificant changes from 4 weeks; *significant difference between control and 
osteoarthritis groups at 0, 4, and 8 weeks, P , 0.05.
Figure 5 Representative radiological results in osteoarthritic (OA group) and 
normal (CON group) knee joints at 0, 4, and 8 weeks (white arrowhead, bone 
erosion and osteophyte formation).
Abbreviations: OA, osteoarthritis; CON, control group.
OA CON
Original magnification × 20
Figure 6 Representative histological sections of osteoarthritis (OA group) and 
normal (CON group) knee joints (black arrowheads in the ×20 magnification of 
the OA section show bone erosion, inflammation, pannus formation, and synovial 
hypertrophy). 
Abbreviations: OA, osteoarthritis; CON, control group.
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Discussion and conclusion
Studies with animal models of induced OA are currently 
being carried out to understand better the bone characteristics 
in degenerative arthritis.7,13–17,19,20 Behets et al,13 Calvo et al,14 
El Hajjaji et al,15 and Intema et al20 analyzed the bone-
characteristic changes in OA using animal models of 
surgically induced secondary OA, generally by performing 
anterior cruciate ligament transaction or menisectomy. 
However, these methods may generate inconsistent results, 
due to the progression of various uncontrolled weight-
bearing patterns, and result in generating unexpected and 
unsuitable bone-characteristic changes induced by primary 
OA. The animal model of MIA-induced nontraumatic OA was 
therefore applied to overcome this limitation in this study.
MIA-induced OA is effective because it is simple to 
perform and induces a similar form of OA by activating 
matrix metalloproteinases, suppressing proteoglycan 
synthesis and inducing cartilage necrosis.21 Despite its 
simplicity and appropriateness, this method has a limitation 
in that the symptoms of OA increase with MIA dose.18 
However, the time of OA symptom onset was 15–21 days 
after injection of 0.3–3 mg of MIA, and the severity of OA 
is consistent in terms of histological scoring (ie, histological 
score 21.56 ± 0.50 at 0.3 mg, 22.78 ± 0.49 at 3 mg). Indeed, 
1 mg MIA was used to induce OA in the studies by Piscaer 
et al7 and Guzman et al,19 as it was in the present study. 
Nevertheless, the previous studies were limited in terms of 
detecting different changes in bone microarchitecture because 
they evaluated the degree of induced OA by examining the 
level of proteoglycan loss in cartilage, histological scoring, 
and bone quantity.7,18,19,24,25 Therefore, additional studies are 
needed to determine the MIA dose after inspecting the degree 
of induced OA according to MIA dose in view of the changes 
in bone microarchitecture. This will be investigated in a future 
study, the results of which may increase confidence in the 
results presented here.
The results obtained in the present study indicate that 
OA causes no damage to trabecular bone microarchitecture 
in the tibial epiphysis until 4 weeks after OA induction. 
However, at 8 weeks, significant changes were noted. Other 
than Tb.N, all other microarchitectural parameters decreased, 
and BS/BV, Tb.Sp, and Tb.Pf increased significantly in the 
OA group (P , 0.05). Thus, the bone-volume fraction 
decreased and bone turnover rate was accelerated in the 
OA group, and subsequently trabecular bone thickness 
decreased and trabecular bone connections became weaker. 
However, no significant changes were observed in trabecular 
bone number, despite the huge quantitative loss of BV/TV, 
meaning that the loss of BV/TV was caused by trabecular 
bone thickness rather than trabecular bone number. Thus, 
the reduced BV/TV was due to further trabecular bone 
separation caused by reduction in trabecular bone thickness. 
These facts were verified by analysis of both Tb.Th and 
Tb.Sp distribution specif ically. Having examined the 
result of the distribution, the proportion of relatively thin 
trabecular bone increased, while that of thick trabecular bone 
decreased as OA progressed. Also, the percentage of close 
trabecular bone separation decreased and that of distant 
trabecular bone separation increased. This indicates that 
the quantitative loss of trabecular bone microarchitecture 
caused by the qualitative loss may eventually occur during 
the course of OA. In previous reports on trabecular bone 
microarchitecture characteristics 8 weeks after induction 
of OA, BV/TV, Tb.Th, and Tb.Sp of the OA group showed 
about 41.1%, 28.8%, and 75.9% differences, respectively, 
compared to the normal group in a study by Kamibayashi 
et al.12 Also, BV/TV, Tb.Th, Tb.Sp, and Tb.Pf of the OA 
group showed about 18.2%, 7.0%, 2.8%, and 33.3% 
differences, respectively, compared to the normal group in 
a study by Koh et al.17 In the case of previous reports on 
changes in vBMD after induction of OA, McErlain et al27 
reported that no significant difference in vBMD was shown 
comparing 4 to 0 weeks in the OA group (P . 0.05), whereas 
significant differences were shown at 8 weeks compared to 
0 weeks (OA approximately 26% difference, P , 0.05), 
and Batiste et al28 also reported that vBMD was decreased 
significantly through 4–8 weeks postinduction in the OA 
group (approximately 20% decrease of vBMD, P , 0.01). 
Taken together, OA caused a reduction in trabecular bone 
microarchitecture and vBMD compared to controlled knee 
joints. The results are similar to the pattern of vBMD and 
bone microarchitecture reduction in this study.
Nevertheless, numerical differences in trabecular bone 
microarchitectural parameters occurred compared with 
previous studies. In other words, the level of OA symptoms 
and its progress can be affected by the undefined individual 
animal’s ability to adapt, which itself depends on its 
difference of individual physical ability, eating habits, or by 
the hands of different invesitigators.23 Therefore, one must 
analyze the level of undefined individual adaptation ability 
by quantifying the results of video-camera monitoring of 
real-time behavioral patterns, along with regular clinical 
and pathological examination of animals; one can thereby 
improve the accuracy of results. Therefore, we are currently 
investigating these ideas in an ongoing study, the results of 
which may increase confidence in the results presented here. 
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Inspection of trabecular bone microarchitecture changes 
according to the MIA dose, correlation between changes in 
cartilage and those in the endochondrial microarchitecture, 
the elimination of experimental errors, detailed trace studies, 
and analysis of real mechanical rigidity changes in trabecular 
bone microarchitecture will improve the reliability of 
our conclusions. We plan to undertake this research and 
publish the results. However, the significance of the data we 
present here is that they overcome some of the limitations 
of previous studies by tracing changes in trabecular 
bone microarchitecture characteristics continuously and 
individually. The analytical method used in this study is also 
expected to be applied to analyze the efficacy of various 
anti-inflammatory and antiresorptive agents in terms of 
improvements in trabecular bone quality.
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